CAS 77335-18-3

Formula: C5H12ClN

InChI: InChI=1S/C5H11N.ClH/c1-6-4-5-2-3-5;/h5-6H,2-4H2,1H3;1H

InChI key: ORQVLOOOUXHZEJ-UHFFFAOYSA-N

SMILES: CNCC1CC1.Cl

(Cyclopropylmethyl)methylamine hydrochloride

CAS: 77335-18-3

(Cyclopropylmethyl)methylamine hydrochloride

Formula: C₅H₁₁N·ClH

Purity: >97%

Molecular weight: 121.60848

Ref: 54-OR902516

N-(Cyclopropylmethyl)-N-Methylamine Hydrochloride

CAS: 77335-18-3

Formula: C₅H₁₂ClN

Purity: 97%

Color and Shape: Solid

Molecular weight: 121.6085

Ref: IN-DA00G3DJ

N-(Cyclopropylmethyl)-N-methylamine Hydrochloride

CAS: 77335-18-3

N-(Cyclopropylmethyl)-N-methylamine Hydrochloride

Formula: C₅H₁₂ClN

Purity: 98%

Molecular weight: 121.61

Ref: IN-DG285346

Cyclopropylmethyl-methyl-amine hydrochloride

CAS: 77335-18-3

Formula: C₅H₁₂ClN

Purity: 95%

Color and Shape: Solid

Molecular weight: 121.61

Ref: 10-F037309

(Cyclopropylmethyl)methylamine hydrochloride

CAS: 77335-18-3

Cyclopropylmethylmethylamine hydrochloride (CPMMA) is an experimental drug that belongs to the class of medicaments. It is a selective cannabinoid receptor type 1 (CB1) agonist which has been shown to reduce infarct size in animal models of myocardial reperfusion injury. CPMMA also has angiogenic and anti-inflammatory properties, which may be due to its ability to decrease cholesterol levels and inhibit the production of vascular endothelial growth factor (VEGF). This agent has potential as a treatment for hypercholesterolemia, coronary artery disease, and other cardiovascular disorders.

Formula: C₅H₁₂NCl

Purity: Min. 95%

Molecular weight: 121.61 g/mol

Ref: 3D-CDA33518